- Merck (NYSE:MRK +0.3%) announces that Ervebo (Ebola Zaire Vaccine, Live) is now approved in Democratic Republic of Congo, Burundi, Ghana and Zambia for prevention of disease caused by Zaire ebolavirus in people at least 18 years old.
Merck Ebola vaccine OK'd in four African countries
Recommended For You
About MRK Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MRK | - | - |
Merck & Co., Inc. |